SE420097B - Forfarande for framstellning av hydroxialkylxantiner - Google Patents

Forfarande for framstellning av hydroxialkylxantiner

Info

Publication number
SE420097B
SE420097B SE7507726A SE7507726A SE420097B SE 420097 B SE420097 B SE 420097B SE 7507726 A SE7507726 A SE 7507726A SE 7507726 A SE7507726 A SE 7507726A SE 420097 B SE420097 B SE 420097B
Authority
SE
Sweden
Prior art keywords
hydroxial
chylxantines
procedure
preparation
hydroxial chylxantines
Prior art date
Application number
SE7507726A
Other languages
English (en)
Swedish (sv)
Other versions
SE7507726L (sv
Inventor
A Soder
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/485,869 external-priority patent/US4108995A/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7507726L publication Critical patent/SE7507726L/xx
Publication of SE420097B publication Critical patent/SE420097B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
SE7507726A 1974-07-05 1975-07-04 Forfarande for framstellning av hydroxialkylxantiner SE420097B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48587074A 1974-07-05 1974-07-05
US05/485,869 US4108995A (en) 1973-07-11 1974-07-05 Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines

Publications (2)

Publication Number Publication Date
SE7507726L SE7507726L (sv) 1976-01-07
SE420097B true SE420097B (sv) 1981-09-14

Family

ID=27048497

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7507726A SE420097B (sv) 1974-07-05 1975-07-04 Forfarande for framstellning av hydroxialkylxantiner
SE7807853A SE427183B (sv) 1974-07-05 1978-07-14 Mono-(alken-1-yl)-xantiner till anvendning sasom mellanprodukter vid framstellning av terapeutiskt verdefulla hydroxialkylxantinforeningar

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7807853A SE427183B (sv) 1974-07-05 1978-07-14 Mono-(alken-1-yl)-xantiner till anvendning sasom mellanprodukter vid framstellning av terapeutiskt verdefulla hydroxialkylxantinforeningar

Country Status (14)

Country Link
JP (1) JPS5250800B2 (de)
AR (1) AR210330A1 (de)
AT (1) AT339917B (de)
CA (1) CA1062710A (de)
CH (2) CH622519A5 (de)
DK (1) DK140214B (de)
ES (1) ES439141A1 (de)
FI (1) FI59249C (de)
FR (1) FR2277089A1 (de)
GB (1) GB1500039A (de)
LU (1) LU72897A1 (de)
NL (1) NL166476C (de)
NO (1) NO143224C (de)
SE (2) SE420097B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664568A5 (de) * 1984-01-12 1988-03-15 Sandoz Ag 8-alpha-acylaminoergoline.
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Also Published As

Publication number Publication date
AT339917B (de) 1977-11-10
SE427183B (sv) 1983-03-14
CH622519A5 (en) 1981-04-15
FI751958A (de) 1976-01-06
AR210330A1 (es) 1977-07-29
NL7507976A (nl) 1976-01-07
AU8275575A (en) 1977-01-06
JPS5250800B2 (de) 1977-12-27
DK140214B (da) 1979-07-09
NO143224B (no) 1980-09-22
NL166476B (nl) 1981-03-16
JPS5134194A (de) 1976-03-23
DK140214C (de) 1979-12-03
GB1500039A (en) 1978-02-08
LU72897A1 (de) 1976-05-31
FR2277089A1 (fr) 1976-01-30
SE7507726L (sv) 1976-01-07
CA1062710A (en) 1979-09-18
CH622018A5 (en) 1981-03-13
ES439141A1 (es) 1977-02-16
NO752423L (de) 1976-01-06
NO143224C (no) 1981-01-02
DK301775A (de) 1976-01-06
FR2277089B1 (de) 1978-03-17
NL166476C (nl) 1981-08-17
SE7807853L (sv) 1978-07-14
FI59249B (fi) 1981-03-31
ATA517275A (de) 1977-03-15
FI59249C (fi) 1981-07-10

Similar Documents

Publication Publication Date Title
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
NO145075C (no) Kontinuerlig fremgangsmaate til fremstilling av alkoksysilaner
NO142196C (no) Fremgangsmaate for fremstilling av avfarvede kaldtvannsopploeselige tegarvestoffer
SE7513085L (sv) Forfarande for framstellning av etrar
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
SE431207B (sv) Forfarande for framstellning av tiazolidinderivat
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE427925B (sv) Forfarande for framstellning av o-hydroxibensylalkoholer
SE431547B (sv) Forfarande for framstellning av 3-metylencefamsulfoxider
SE7505751L (sv) Forfarande for framstellning av cefalosporiner
SE418395B (sv) Forfarande for framstellning av indanettiksyror
SE423815B (sv) Forfarande for framstellning av aminometylarylmetylpenicilliner
SE420097B (sv) Forfarande for framstellning av hydroxialkylxantiner
SE422679B (sv) Forfarande for framstellning av etynylbensenforeningar
NO149427C (no) Fremgangsmaate for fremstilling av fenyl- henholdsvis naftyl-uretaner.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7507726-3

Effective date: 19940210

Format of ref document f/p: F